This report contains market size and forecasts of 5HT3 Receptor Antagonists in Global, including the following market information:
Global 5HT3 Receptor Antagonists Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global 5HT3 Receptor Antagonists market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dolasetron Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of 5HT3 Receptor Antagonists include Otsuka Pharmaceutical, MedKoo Biosciences, Cipla, Helsinn Healthcare SA, Sanofi, Roche Holding AG, Kyowa Kirin, Heron Therapeutics and GlaxoSmithKline and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the 5HT3 Receptor Antagonists companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 5HT3 Receptor Antagonists Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global 5HT3 Receptor Antagonists Market Segment Percentages, by Type, 2021 (%)
Dolasetron
Granisetron
Ondansetron
Palonosetron
Global 5HT3 Receptor Antagonists Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global 5HT3 Receptor Antagonists Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Drugstore
Others
Global 5HT3 Receptor Antagonists Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global 5HT3 Receptor Antagonists Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies 5HT3 Receptor Antagonists revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies 5HT3 Receptor Antagonists revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Otsuka Pharmaceutical
MedKoo Biosciences
Cipla
Helsinn Healthcare SA
Sanofi
Roche Holding AG
Kyowa Kirin
Heron Therapeutics
GlaxoSmithKline
Fortovia Therapeutics